Table 1.
N | Result | ||
---|---|---|---|
Median Age (range) | Years | 201 | 59 (23–81) |
Tumor type | Ductal | 144 | 72% |
Lobular | 30 | 15% | |
Other | 27 | 13% | |
Multiple foci | Yes | 24 | 12% |
Tumor grade | 1 | 17 | 9% |
2 | 149 | 74% | |
3 | 35 | 17% | |
ER-positive | 201 | 100% | |
PR-positive | 166 | 82.5% | |
Surgery type | Lumpectomy | 149 | 74% |
Mastectomy | 52 | 26% | |
Sentinel node dissection | 178 | 89% | |
pT | pT1 | 151 | 75.5% |
pT1a | 1 | ||
pT1b | 34 | ||
pT1c | 116 | ||
pT2 | 44 | 22% | |
pT3 | 5 | 2.5% | |
pN | pN0 | 181 | 90.5% |
pN1mi | 19 | 9.5% | |
EPclin risk class | Low Risk | 135 | 67% |
High risk | 66 | 33% | |
Initial chemotherapy decision | Yes | 96 | 48% |
No | 105 | 52% | |
Final chemotherapy decisiona | Yes | 53 | 26% |
No | 147 | 73% |
One patient was withdrawn from the study due to metastatic disease discovered after accrual.